BW710
BW710 is a potent and selective oral inhibitor of FGFR2, with an IC50 of 2.8 nM in cellular assays. It demonstrates promising oral bioavailability (29% in mice) and is a valuable tool for investigating FGFR2-driven oncogenesis in both in vitro and in vivo cancer research models.
Product Specifications
Field of Research
Cardiovascular Research, Signal Transduction
Molecular Formula
C28H29FN6O2S
Molecular Weight
532.63
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb3031389-01 100 mg
2- (Methylamino) -5- (trifluoromethyl) -1,3,4-thiadiazole
Sign In for Pricing
View Details orb3031389-02 2 mg
2- (Methylamino) -5- (trifluoromethyl) -1,3,4-thiadiazole
Sign In for Pricing
View Details orb3031389-03 10 mg
2- (Methylamino) -5- (trifluoromethyl) -1,3,4-thiadiazole
Sign In for Pricing
View Details